Bruton’s tyrosine kinase inhibition for the prevention of anaphylaxis: an open-label, phase 2 trial

IgE-mediated anaphylaxis is a potentially fatal systemic allergic reaction for which there are no known preventative therapies. Bruton’s tyrosine kinase (BTK) is an essential enzyme for IgE-mediated signaling pathways, and is an ideal pharmacologic target to prevent allergic reactions. In this open-...

Descripción completa

Detalles Bibliográficos
Autores principales: Suresh, Ragha V., Dunnam, Collin, Vaidya, Dhananjay, Wood, Robert A., Bochner, Bruce S., MacGlashan, Donald W., Dispenza, Melanie C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10104202/
https://www.ncbi.nlm.nih.gov/pubmed/37066249
http://dx.doi.org/10.21203/rs.3.rs-2757218/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10104202/
https://www.ncbi.nlm.nih.gov/pubmed/37066249
http://dx.doi.org/10.21203/rs.3.rs-2757218/v1

Ejemplares similares